Jochen Buck

Title: Jochen Buck: Innovator in Soluble Adenylyl Cyclase Research

Introduction

Jochen Buck is a prominent inventor based in Old Greenwich, CT (US). He has made significant contributions to the field of biochemistry, particularly in the area of soluble adenylyl cyclase. With a total of 7 patents, his work has the potential to impact various medical conditions.

Latest Patents

One of his latest patents involves inhibitors of soluble adenylyl cyclase. This invention provides 6-amino substituted 2,6-diamino-4-chloropyrimidine compounds that specifically inhibit soluble adenylyl cyclase. These compounds can be formulated with pharmaceutical carriers and are intended for reducing cyclic AMP levels, which can be beneficial in treating conditions such as ocular hypotony. Another significant patent relates to a method of treating disorders mediated by soluble adenylyl cyclase. This method involves administering an effective amount of a compound that modulates soluble adenylyl cyclase to treat various disorders, including learning or memory disorders, malaria, fungal infections, spinal cord injuries, Alzheimer's disease, amyotrophic lateral sclerosis, and peripheral neuropathy.

Career Highlights

Throughout his career, Jochen Buck has worked with esteemed organizations such as the Cornell Research Foundation Inc. and Cornell University. His research has been pivotal in advancing the understanding of soluble adenylyl cyclase and its implications in various medical fields.

Collaborations

Jochen has collaborated with notable individuals in his field, including Lonny Levin and Leo Brizuela. These partnerships have further enriched his research and contributions to science.

Conclusion

Jochen Buck's innovative work in the realm of soluble adenylyl cyclase has led to significant advancements in medical research. His patents and collaborations reflect his dedication to improving treatment options for various disorders.